Photronics, Inc. (NASDAQ:PLAB – Get Free Report) Director Kang Lee sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 29th. The stock was sold at an average price of $30.75, for a total value of $307,500.00. Following the sale, the director directly owned 337,350 shares of the company’s stock, […]

Alphabet Inc. (NASDAQ:GOOG – Get Free Report) Director Frances Arnold sold 83 shares of the firm’s stock in a transaction that occurred on Wednesday, September 30th. The stock was sold at an average price of $340.45, for a total transaction of $28,257.35. Following the sale, the director directly owned 19,076 shares in the company, valued […]

Sonos, Inc. (NASDAQ:SONO – Get Free Report) Director Karen Boone sold 46,766 shares of Sonos stock in a transaction on Friday, September 25th. The shares were sold at an average price of $18.13, for a total transaction of $847,867.58. Following the transaction, the director owned 69,271 shares in the company, valued at $1,255,883.23. The trade […]

Virtuix Holdings Inc. (NASDAQ:VTIX – Get Free Report) Director Brett Moyer sold 8,700 shares of the stock in a transaction that occurred on Monday, September 28th. The shares were sold at an average price of $1.19, for a total transaction of $10,353.00. Following the sale, the director directly owned 154,958 shares of the company’s stock, […]

Pharvaris N.V. (NASDAQ:PHVS – Get Free Report) Director Viviane Monges sold 11,969 shares of the firm’s stock in a transaction dated Wednesday, September 23rd. The shares were sold at an average price of $33.05, for a total value of $395,575.45. Following the completion of the sale, the director directly owned 5,500 shares in the company, […]

Beta Bionics, Inc. (NASDAQ:BBNX – Get Free Report) Director Christy Jones sold 6,430 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $23.00, for a total transaction of $147,890.00. Following the sale, the director directly owned 19,564 shares of the company’s stock, […]

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) Director Ali Behbahani sold 13,679 shares of the company’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $57.09, for a total value of $780,934.11. Following the completion of the transaction, the director owned 16,637 shares in […]

Pharvaris N.V. (NASDAQ:PHVS – Get Free Report) Director Johannes Gerardus Chri Schikan sold 200,000 shares of the company’s stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $35.00, for a total value of $7,000,000.00. Following the completion of the transaction, the director directly owned 115,167 shares of […]